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SUMMARY
This study investigated the sero-conversion period in which dogs from endemic areas test positive for visceral leishmaniasis (VL) 
as well as the early post-infection period in which renal alterations are observed. Dogs that were initially negative for Canine Visceral 
Leishmaniasis (CVL) were clinically evaluated every three months by serological, parasitological and biochemical tests until sero-
conversion was confirmed, and six months later a subsequent evaluation was performed. Samples of kidney tissues were processed 
and stained with Hematoxylin and Eosin (H&E), Periodic Acid Schiff (PAS) and Masson’s trichrome stain and lesions were classified 
based on the WHO criteria. Of the 40 dogs that initially tested negative for VL, 25 (62.5%) exhibited positive serological tests during 
the study period. Of these 25 dogs, 15 (60%) tested positive within three months, five (20%) tested positive within six months and five 
(20%) tested positive within nine months. The dogs exhibited antibody titers between 1:40 and 1:80 and 72% of the dogs exhibited 
clinical symptoms. The Leishmania antigen was present in the kidneys of recently infected dogs. We found higher levels of total 
protein and globulin as well as lower levels of albumin in the infected dogs when compared to the control dogs. Additionally, infected 
dogs presented levels of urea and creatinine that were higher than those of the uninfected dogs. Glomerulonephritis was detected in 
some of the dogs examined in this study. These data suggest that in Teresina, the sero-conversion for VL occurs quickly and showed 
that the infected dogs presented abnormal serum proteins, as well as structural and functional alterations in the kidneys during the 
early post-infection period.
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INTRODUCTION
Visceral Leishmaniasis (VL) is a form of zoonosis that is caused 
by protozoa of the genus Leishmania1,2. In Latin America, Leishmania 
(Infantum) chagasi is the predominant disease-causing species8,24,25,31,47,48. 
Infected dogs can exhibit a marked humoral immune response 
characterized by high levels of IgG anti-Leishmania antibodies, which, 
despite their upregulation, do not confer protection20. It is estimated 
that the time between infection and sero-conversion ranges from three 
months to seven years6.
Despite the wide range of tests already developed, the indirect 
fluorescent antibody test (IFAT) is the conventional method that is 
currently employed for epidemiological canine surveys. The euthanasia 
of dogs that test positive is a measure recommended by the Ministry of 
Health for the control of VL16,34,37,43. This measure was recommended 
as the result of canine populations constituting a major reservoir 
of the disease, representing the threat of canine-to-human disease 
transmission3,35. The determination of the precise CVL sero-conversion 
period in endemic areas therefore represents an important factor in the 
control of VL.
By IFAT, dogs with high antibody titers are associated with 
active parasitism, the presence of clinical symptoms16 and an elevated 
probability of the presence of amastigotes as detected by parasitological 
examination17,40,42. It has therefore been suggested that the serological 
profile be used as an indicator for susceptibility or resistance 
to CVL5,16.
Dogs affected with VL generally present with renal changes11, 
manifested specifically by glomerulonephritis and interstitial nephritis14. 
Despite the high prevalence of renal pathologies, the development of 
renal failure is only evident when two thirds to three quarters of the renal 
tissue in both kidneys is compromised27.
Kidney disease in CVL can progress from mild proteinuria to 
nephrotic syndrome, developing progressively into renal failure, which is 
the leading cause of death among dogs11. The clinical evolution of CVL 
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therefore promotes serological, parasitological and biochemical changes 
which directly correlate with the clinical status of the affected dog. 
This study aims to define the time period in which dogs seroconvert 
during VL infection in the endemic area of Teresina in the state of Piauí, 
and to evaluate the functional and structural impairment of the kidneys 
during the early post-infection period.
MATERIALS AND METHODS
From a population of 88 dogs from the University Veterinary Hospital, 
40 (70.1%) dogs which tested negative for VL were monitored in their 
homes every three months for one year. The dogs examined in this study 
ranged from eight months to 12.2 years of age and both males and females 
of undefined races were included. The animals were evaluated clinically 
for the diagnosis of CVL and were subjected to blood collection, bone 
marrow aspiration and popliteal lymph node biopsy under sedation and 
local anesthesia.
The detection of Leishmania using anti-Leishmania antibodies was 
performed by IFAT (lote 08ULC0127/Biomanguinhos/FIOCRUZ, Rio 
de Janeiro, RJ, Brazil) in sera diluted at 1:40, 1:80, 1:160 and 1:320. 
Parasitological examinations were performed on smears of popliteal 
lymph node aspirates and bone marrow samples. The uninfected dogs 
were monitored by clinical and parasitological examination and IFAT at 
the homes of their owners every three months for a maximal period of one 
year until the time of sero-conversion, whereupon the dogs were separated 
into the following three groups: 11 dogs with anti-Leishmania antibodies 
and more than three clinical symptoms for VL (seropositive), seven dogs 
with anti-leishmania antibodies and up to three clinical symptoms for VL 
(seropositive) and seven dogs exhibiting positive serology (seropositive) 
and no clinical symptoms for VL41. The control group was comprised 
of 11 uninfected dogs without clinical symptoms for VL. For clinical 
evaluation, we considered the following manifestations: skin lesions, 
lymphadenopathy, onychogryphosis, weight loss, alopecia, conjunctivitis, 
pale mucous membranes, muzzle keratinization, depigmentation of the 
muzzle, edema and apathy.
The characterization of Leishmania species was performed using PCR 
on kidney samples from dogs exhibiting positive serological profiles for 
VL, using sequences from the ITS (internal transcribed spacer) of the 
ribosomal RNA (rRNA) gene.
The experimental protocols used in this study were approved by the 
Ethics Committees on Animal Experimentation of the Federal University 
of Piauí under No. 015/2010.
After an interval of five months of sero-conversion, blood samples 
were further collected from nine dogs exhibiting positive serology to 
monitor renal function.
Serum samples were used to assess the levels of urea (Labtest No. 
104-4), creatinine (kit Labtest No. 35), total protein (Labtest No. 99) and 
albumin (Labtest No. 19) using the semi-automated SB 190 method. The 
results were analyzed based on normal values for the species22.
We evaluated 40 dogs which tested negative for CVL and were 
distributed among various neighborhoods of the city of Teresina in the 
state of Piauí, including the districts of moderate transmission (Santo 
Antonio, Angelim and Satélite)18. The twenty-seven total neighborhoods 
in the city of Teresina visited to collect materials were distributed among 
five urban areas: Central, North, East, South and Southeast45.
The six dogs that were determined to be positive for VL by serological 
or parasitological examination and that presented more than three 
clinical symptoms for VL (seropositive) were enrolled for study with 
the permission of the owners, who signed a consent form. The dogs 
were transported to the sector of Animal Pathology of UFPI, where they 
were anesthetized with sodium thiopental 25 mg/kg intravenously15,32, 
euthanized and necropsied to collect kidney samples. The tissue samples 
were formalin-fixed, paraffin-embedded and then processed and stained 
with H&E, PAS and Masson’s trichrome stains27. Other renal tissue 
samples were prepared and subjected to immunohistochemical analysis 
using a mouse polyclonal, anti-Leishmania amazonensis antibody 
at a dilution of 1:400 and the EnVision + peroxidase system for the 
amplification reaction (Dako Corporation Carpinteria, CA, USA, catalog 
number K4002). The signal development was performed using 0.3 mg/mL 
3,3'-diaminobenzidine in PBS containing 0.06% hydrogen peroxide and 
counterstained with Harry’s hematoxylin stain.
The renal abnormalities were classified according to the criteria of 
the World Health Organization to define the morphological patterns of 
glomerulonephritis9,51. The data were tabulated, graphed and analyzed 
using Sigma Stat statistical software (Bioestat, 5.0) for non-parametric 
tests (Mann-Whitney U test). p-values < 0.05 were considered statistically 
significant.
RESULTS
From a population of 88 dogs from the University Veterinary Hospital, 
57 (64.7%) dogs that initially tested negative for CVL comprised the 
sero-conversion study group in our investigation. Of this group, 40 dogs 
(70.1%) were monitored in their homes every three months for one year.
Of the 40 dogs that initially tested negative for VL, 25 (62.5%) 
exhibited positive serologic tests during the study period. Of these dogs, 
15 (60%) tested positive within three months (2nd serum collection), five 
(20%) tested positive within six months (3rd serum collection) and five 
(20%) tested positive within nine months (4th serum collection).
The PCR performed on samples of renal tissue from three dogs 
confirmed that the infection was caused by Leishmania (infantum) chagasi.
At the 12-month follow-up of the VL-positive dogs, 11 (44%) 
developed more than three clinical symptoms, seven (28%) presented 
up to three clinical symptoms and seven (28%) did not develop clinical 
symptoms. The percentage of dogs that tested positive for VL without 
manifesting clinical symptoms was therefore less (28%) than that of 
animals that presented clinical symptoms (72%). Clinical symptoms, 
such as lymphadenopathy and skin lesions, were the most frequent 
manifestations observed (Fig. 1).
Of the 18 dogs presenting clinical manifestations of VL (11 with more 
than three clinical symptoms and seven with up to three symptoms), 10 
tested positive within an interval of three months (seven with more than 
three clinical symptoms and three with up to three clinical symptoms) 
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and in the group of dogs without clinical symptoms, five also tested 
positive within an interval of three months. The largest number of dogs 
that tested positive for VL during the study period were those located 
within the urban neighborhoods of the North (24%) and South (24%), 
followed by the urban neighborhoods of the Central (20%), East (16%) 
and Southeast (16%) regions.
To evaluate the main indices of the health status of these animals that 
might contribute to disease progression, we performed serological and 
biochemical tests to evaluate renal function, followed by histopathological 
examination of the kidney tissue samples.
The majority of the dogs presented serological titers of anti-
Leishmania antibodies between 1:40 and 1:80, regardless of their 
presentation of clinical symptoms. Although we found higher values 
of urea, creatinine and total protein in infected dogs than in uninfected 
dogs (Table 1), the differences that we observed were not significant. 
However, comparison of the data revealed that total protein (Mann-
Whitney rank sum test, p = 0.0302) and globulin (t-test, p = 0.0214) 
values were significantly higher and that albumin values were (t-test, p 
= 0.0386) significantly lower in the infected dogs presenting with more 
than three clinical symptoms compared to the dogs in the control group 
(Fig. 2). The results of the biochemical measurements of the infected 
and uninfected dogs as well as the reference values are shown in Table 1.
Renal function tests revealed that among the 25 infected dogs, two 
(8%) presented with urea (dogs No. 20 and 23) and creatinine (dogs No. 
2 and 10) levels that were above the normal range (Table 1). In general 
however, infected dogs presented with elevated blood urea nitrogen 
(BUN) and creatinine levels that were higher than in uninfected dogs 
(Fig. 3), although the differences were not significant.
Six newly infected dogs were euthanized for histological examination 
to evaluate the renal lesions. All of the dogs presented with two or more 
clinical symptoms of VL, such as weight loss, keratinization on the 
nose, conjunctivitis, skin lesions, seborrhea, enlarged lymph nodes, 
onychogryphosis and alopecia.
Microscopic examination revealed glomerulonephritis (GN) in five 
dogs, minimal change GN in two dogs (dogs Nos. 14 and 16), focal 
segmental glomerulosclerosis in one dog (dog No. 13) (Fig. 4A) and 
membranoproliferative GN (Fig. 4B) in two dogs (dog No. 4 and 8), 
according to previously described morphological characteristics12. 
The glomerular lesions were focal and of medium intensity. 
Perivascular mononuclear inflammatory infiltrates were observed in 
the corticomedullary and cortical regions that were proximal to blood 
vessels and tubules, ranging in intensity from minimal to average (Fig. 
4C). Hyaline casts (Fig. 4D) were present in two dogs, one with minimal 
change GN and one with focal segmental glomerulosclerosis, which 
exhibited normal urea and creatinine levels. The PAS staining revealed 
the presence of medium intensity tubular atrophy with focal distribution 
Fig. 1 - Clinical manifestations observed in dogs naturally infected with L (Infantum) chagasi 
in the early post-infection period. (A) Onychogryphosis and skin lesions (ungueal region). (B) 
Enlarged popliteal lymph node. (C) Skin lesions (ear). (D) Skin lesions (muzzle).
Fig. 3 - The mean values of urea (U) and creatinine (C) in control dogs compared to dogs 
naturally infected by Leishmania (Infantum) chagasi in an early post-infection period.
Fig. 2 - The mean values of total proteins, albumin and globulin in the serum samples of 11 
control dogs and 11 naturally infected dogs by Leishmania (Infantum) chagasi presenting 
with more than three clinical symptoms, *p < 0.05.
ALVES, G.B.B.; SILVA, L.S.; BATISTA, J.F.; CAMPOS, A.P.; PRIANTI, M.G. & COSTA, F.A.L. - The sero-conversion and evaluation of renal alterations in dogs infected by Leishmania 
(Infantum) chagasi. Rev. Inst. Med. Trop. Sao Paulo, 55(2): 105-12, 2013.
108
Table 1
Results of biochemical tests of uninfected dogs and dogs that were naturally infected with Leishmania (Infantum) chagasi during a recent post-infection period.  
Teresina, Piauí, Brazil
Clinical status of the dogs 
Reference values*
Ages (year) Sero- 
conversion Serology District 
Urea 
(mg/dL)
21– 60
Creatinine 
(mg/dL)
0.5 – 1.5 
Protein 
(g/dL)
5.4 – 7.1 
Albumin 
(g/dL)
2.6 – 3.3 
Globulin 
(g/dL)
2.7- 4.4 
Dogs presenting 
with more than 
three clinical 
symptoms
1 23.5 0.7 7.7 2.90 4.80 3.7 3 months 1:40 Central
2 43.4 16.2 15.2 2.70 12.50 10 3 months 1:40 South
3 8.0 0.9 10.3 1.73 8.57 6 6 months 1:40 South
4 21.0 1.0 9.4 2.82 6.58 4 6 months 1:40 North
5 15.0 1.5 8.6 3.12 5.48 4 3 months 1:80 North
6 58.0 0.9 9.3 3.16 6.14 4.9 9 months 1:80 South
7 27.0 1.4 8.9 2.91 5.99 3 3 months 1:80 North
8 21.0 0.8 9.7 2.94 6.76 6.5 3 months 1:80 North
9 13.0 1.0 9.5 3.18 6.32 10.7 3 months 1:40 Central
10 54.0 1.6 9.8 2.38 7.42 3.10 3 months 1:40 Central
11 26.0 1.2 9.0 2.73 5.25 3.5 6 months 1:80 Central
Dogs presenting 
up to three clinical 
symptoms
12 57.0 1.1 9.1 3.39 5.71 6.7 9 months 1:40 East
13 42.1 1.4 8.2 2.10 6.10 10 3 months 1:40 Southeast
14 28.0 1.2 10.7 3.42 7.28 6 3 months 1:40 Southeast
15 55.0 1.3 8.2 3.49 4.71 3.8 9 months 1:80 South
16 15.0 1.1 8.8 3.16 5.64 4.6 6 months 1:80 South
17 8.0 1.2 8.4 2.80 5.60 6.5 3 months 1:80 South
18 56.0 1.1 7.2 2.87 4.33 4.5 9 months 1:40 South
Dogs with no 
clinical symptoms
19 38.4 1.0 10.8 2.87 7.95 7.11 3 months 1:40 North
20 92.0 0.9 10.2 4.63 5.57 2 9 months 1:40 East
21 44.1 1.2 6.5 2.90 3.60 10 3 months 1:80 East
22 30.2 1.0 8.4 2.30 6.10 5.5 3 months 1:160 East
23 69.0 1.0 6.0 3.21 2.79 3.1 3 months 1:40 South
24 48.0 1.3 6.9 2.26 4.64 8.1 3 months 1:320 South
25 38.0 1.0 8.4 4.50 3.84 7.6 6 months 1:40 Central
Control dogs
1 28.3 1.3 9.6 2.90 6.73 9.11 Negative Negative East
2 47.3 1.0 7.0 3.93 3.07 2 Negative Negative East
3 42.6 0.9 9.6 3.36 6.27 7.11 Negative Negative East
4 32.3 1.0 6.6 3.81 2.79 3.2 Negative Negative North
5 41.3 1.0 7.8 3.51 4.35 3.7 Negative Negative East
6 54.6 1.3 7.7 3.85 3.91 4.11 Negative Negative South
7 31.6 0.9 8.2 2.70 5.56 12.2 Negative Negative East
8 14.6 1.1 9.0 1.97 7.05 9.5 Negative Negative Central
9 26.0 1.0 9.5 3.03 6.47 5.7 Negative Negative South
10 20.6 1.1 7.7 3.36 4.40 9.8 Negative Negative North
11 43.0 1.2 6.7 3.40 3.29 2.11 Negative Negative Central
KANEKO et al., 2007.
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in one dog. Immunostaining of the Leishmania antigen was observed in 
glomerular cells, in tubular epithelial cells (Fig. 4E) and in inflammatory 
cells of all the recently infected dogs.
DISCUSSION
Of the 40 dogs that tested negative, it was possible to monitor the 25 
dogs that subsequently tested positive for VL during the study period. The 
loss of follow-up of 15 dogs was attributed to the death of some dogs, the 
owners’ absence due to travel which precluded the collection of material, 
the change of owners from other cities and even the refusal of owners to 
continue their participation in our study. Although such obstacles have 
been previously described by other studies49, these difficulties hampered 
the monitoring and evaluation of all of the animals.
We observed that the dogs in the endemic areas of Teresina became 
infected within a short period of time, with 60% seroconverting after 
three months of follow-up. Increased periods of sero-conversion were 
observed in similar studies. In the endemic areas of Rio de Janeiro, 60 
dogs were examined and 50% became seropositive over one year49. A 
study of 23 dogs in an endemic area of Italy revealed that 19 dogs tested 
PCR- or IFAT-positive at eight months and that four dogs tested positive 
after 12 months39. The results of sero-conversion in this study represent 
a unique epidemiological parameter for the endemic areas of Teresina, 
contributing to the improved control of VL. This new information can 
serve as a guideline for the sampling frequency for analysis, for the faster 
identification of seropositive dogs and for the expedited removal of the 
animals from the areas’ transmission. Because of the findings highlighted 
above, similar studies have been conducted in other regions1,7,30,36,37,38,49. 
However, the results were unique to each particular endemic area because 
each area has its own specific characteristics related to the canine 
population, socio-economic conditions of the human population, health 
conditions, sanitation and vector populations with different densities.
During the one-year follow-up, we found that most of the 25 
seropositive dogs presented with more than three clinical symptoms. 
A study of 12 dogs experimentally infected with L. infantum followed 
over a period of six months showed that all dogs became positive within 
four months after infection. The dogs presented with clinical symptoms 
such as lymphadenopathy and lesions of skin29, which are similar to the 
results of this study in which dogs were naturally infected.
Our results therefore suggest that even with short infection times, 
the presence of clinical manifestations contributes to the transmission of 
VL, as has been demonstrated in other studies33,44,50. The dogs in Teresina 
can contribute greatly to the intensification of the infectious cycle of the 
disease, which is demonstrated by the high incidence of CVL in this city.
According to our results, a larger number of infected dogs were 
domiciled in the North and South urban districts of Teresina city. 
Currently, more intense control measures (vector control by spraying with 
insecticides) have been used in six districts of the urban zone of Teresina, 
two of which are located in the North district (Santa Maria da Codipi, 
Pedra Mole), three of which are in the South district (Santo Antonio, 
Angelim, Esplanada) and one in the Southeast district (Satellite). These 
districts are reported to have an average of three to five cases/year of 
human visceral leishmaniasis18, confirming its high transmissibility. The 
factors related to the high incidence of disease in these urban areas46 were 
associated with poor sanitation systems. Of the 169,771 households in 
Teresina, only 22,108 (13.06%) have a general network of sewers18. These 
areas are characterized by high levels of poverty, low-income families, 
households with poor living conditions, unpaved streets, close proximity 
to natural lakes surrounded by slums as observed in the Northern region 
and poor infrastructure, all of which contribute to the high transmission 
rates of VL18.
In general, the dogs that become seropositive for VL and that are 
more susceptible to the disease have high titers of anti-Leishmania 
antibodies20. In the present study, we found low titers of anti-Leishmania 
antibodies among the dogs examined. In this regard, there are two 
serological profiles for dogs with VL. The first is a profile in which the 
animals initially have low antibody titers which remain low, whereas in 
the other profile the dogs start with low antibody titers but they tend to 
increase over the period of infection49. Our study is consistent with these 
profiles because most of the dogs examined exhibited low antibody titers 
when they subsequently tested positive for VL, despite later developing 
Fig. 4 - The kidney of a dog that was naturally infected by Leishmania (Infantum) chagasi. 
(A) Focal segmental glomerulosclerosis (arrows) (dog No. 13). Trichrome Masson staining. 
Magnification: 40x. (B) Thickening of the capillary basement membrane glomerular (arrows) 
in case of membranoproliferative glomerulonephritis (dog No. 8). PAS staining. Magnification: 
40x. (C) Mononuclear inflammatory infiltrate (arrow) (dog No. 8). H-E staining. 
Magnification: 40x. (D) Hyaline casts (arrow) (dog No. 16). PAS staining. Magnification: 
40x. (E) Leishmania antigen in glomerular and tubular epithelial cells. Immunoperoxidase 
staining. Magnification: 40x.
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clinical manifestations. The fact that most of the dogs in our study did not 
exhibit a positive parasitological examination can be explained by the low 
antibody titers observed, considering that a positive parasitological test 
is directly related to an increase in antibody titers28,40,42. This issue still 
requires further clarification because the dogs without clinical symptoms 
can exhibit high titers of antibodies without presenting parasitological 
positivity in the cultures of popliteal lymph node aspirate49.
Most of the dogs that seroconverted, especially the group presenting 
with more than three clinical symptoms, exhibited hyperproteinemia 
that was attributed to hyperglobulinemia and was significantly increased 
compared to the control dogs. These results revealed that even dogs 
that were recently infected exhibited changes in serum protein levels, 
indicating the importance of hyperproteinemia and particularly of 
hyperglobulinemia as potential diagnostic markers for CVL, consistent 
with previous studies14,19,43. In contrast, previous studies have also shown 
that dogs without clinical manifestations exhibited reduced antibody 
titers, lower levels of total protein and of globulin and increased albumin-
globulin ratios4, which differs from our findings of hyperglobulinemia 
and hypoalbuminemia in infected dogs without clinical symptoms and 
is similar to dogs with clinical manifestations.
The increased levels of total protein, globulin, urea and creatinine and 
the lower levels of albumin observed in four infected dogs compared to 
control dogs indicate that dogs with VL tend to present with alterations 
in renal function at early stages of infection without the subsequent 
development of renal failure. Renal failure is a predominant cause of 
death in dogs with progressive VL11. Studies of chronically infected dogs 
of the endemic areas of São José de Ribamar in the state of Maranhão 
found high levels of urea, without changes in creatinine levels14. These 
higher levels of urea in a greater number of dogs might be attributed to 
pre-existing liver disease26, which is a possibility that we cannot exclude 
for the dogs examined in this study since VL can cause liver damage44. 
AMUSATEGUI et al.4 showed that at advanced stages of CVL, the mean 
values of urea and creatinine were high, whereas the dogs in the initial phase 
of infection exhibited lower levels of antibodies. Furthermore, the levels of 
urea and creatinine did not differ from those found in control dogs, which 
is consistent with our findings. We suggest that the biochemical assessment 
of serum from dogs with VL should be taken into account together with 
other biochemical analyses to aid in the diagnosis and assessment of the 
progression of infection, as has also been proposed in other studies14,23.
The six infected dogs were euthanized for the collection of kidney 
tissue samples and the subsequent analysis of renal lesions. These dogs 
presented with clinical symptoms and exhibited positive serological 
or parasitological tests. The limited number of animals euthanized 
has been justified by difficulties also observed by SILVA et al.49, who 
reported that the elimination of dogs without clinical symptoms of VL is 
difficult, as the owners do not easily relinquish their dogs for euthanasia. 
Furthermore, we observed that many owners of infected dogs preferred 
treatment over euthanasia.
Using immunohistochemistry, the Leishmania antigen was observed 
in glomerular cells, tubular epithelial cells and interstitial inflammatory 
cells, confirming the relationship between Leishmania and renal lesions, 
which is consistent with our previous studies11,12,13. Two dogs with normal 
levels of urea and creatinine exhibited hyaline casts (Dogs. No. 4 and 
16) in renal tubules, demonstrating that proteinuria can occur even in the 
absence of severe structural changes of the kidneys, as observed by light 
microscopy in the cases of minimal change GN and of medium intensity 
membranoproliferative GN51,52 present in these dogs.
The description of the patterns of glomerular lesions diagnosed 
in this study was previously described by COSTA et al.11. The results 
revealed that the glomerular lesions are present in the early phase of 
natural infection by Leishmania (Infantum) chagasi, although we cannot 
completely exclude the possibility of other pre-existing infections, even 
when examining resident dogs. In general, the glomerular and tubular 
interstitial changes were of low intensity, with mild elevation of BUN 
and creatinine levels in infected dogs compared to uninfected dogs. 
However, these changes were insufficient to cause renal failure, which 
is consistent with the results from nephropathy studies, emphasizing that 
the functional alterations of the kidneys are observed only when 2/3 or 
3/4 of tissue from both kidneys is impaired10,21,26.
The infected dogs monitored for one year that were not euthanized 
after six months were again subjected to biochemical blood analyses 
to assess renal function. Based on biochemical evidence, there was no 
worsening of renal function. The renal changes that occur during the 
course of CVL progression are therefore likely to evolve slowly, as these 
changes were not detected by any biochemical tests regardless of the 
post-infection time period, but rather were detected by histopathological 
examination in the recently infected dogs.
Based on the results of this study, we found that Teresina sero-
conversion to CVL occurs within a short time period (within three months 
of exposure) and that the infected dogs are therefore quickly included in the 
epidemiological pool of VL transmitters, contributing to the maintenance 
and spread of the disease. Most newly infected dogs presented with 
clinical symptoms of VL but did not exhibit high titers of anti-Leishmania 
antibodies. The infected dogs exhibited changes in serum proteins as well as 
high levels of urea and creatinine compared to uninfected dogs, which are 
likely to result from the renal lesions which must be taken into account for 
the early diagnosis of VL. Finally, we suggest that the sero-epidemiological 
surveys for CVL in Teresina must be performed within shorter time periods 
than it is performed currently (annually).
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RESUMO
Soro-conversão e avaliação das alterações renais em cães 
infectados por Leishmania (Infantum) chagasi
Este estudo investigou o período em que o cão torna-se positivo para 
leishmaniose visceral (VL) em área endêmica e as alterações renais no 
período recente pós-infecção. Cães negativos para VL foram avaliados 
clinicamente a cada três meses por testes sorológicos, parasitológicos 
e bioquímicos até a soro-conversão e seis meses após. Foram colhidos 
tecido renal de seis cães, submetidos a processamento de rotina e 
corados com HE, PAS e Masson e as lesões foram classificadas com 
base nos critérios da OMS. Dos 40 cães nagativos para VL, 25 (62,5%) 
apresentaram sorologia positiva durante o estudo. Desses, 15 (60%) 
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tornaram-se positiva nos primeiros três meses, cinco (20%) tornaram-se 
positivas dentro de seis meses e cinco (20%) tornaram-se positivas dentro 
de nove meses. Os cães apresentavam títulos de anticorpos entre 1:40 e 
1:80, e 72% mostraram sinais clínicos. Antígeno de Leishmania estava 
presente no rim. Foram encontrados níveis mais elevados de proteína 
total e globulina, e menores níveis de albumina em cães infectados 
quando comparados aos controles. Além disso, os cães infectados 
apresentaram níveis de uréia e creatinina maior do que os cães controles. 
Glomerulonefrite foi observada em cinco cães. Os resultados sugerem 
que em Teresina a soro-conversão para VL ocorre rapidamente e os cães 
apresentam proteínas séricas anormais e alterações na estrutura e função 
dos rins em um período recente pós-infecção.
REFERENCES 
 1. Almeida ABPF, Faria RP, Pimentel MFA, Dahroug MAA, Turbino NCMR, Sousa VRF. 
Inquérito soroepidemiológico de leishmaniose canina em áreas endêmicas de Cuiabá, 
Estado de Mato Grosso. Rev Soc Bras Med Trop. 2009;42:156-9.
 2. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22:552-7.
 3. Alves WA, Bevilaqua PD. Reflexões sobre a qualidade do diagnóstico da leishmaniose 
visceral canina em inquéritos epidemiológicos: o caso da epidemiologia de Belo 
Horizonte, Minas Gerais, Brasil, 1993-1997. Cad Saude Publica. 2004;20:259-65.
 4. Amusategui I, Sainz A, Rodriguez F, Tesouro MA. Distribution and relationships between 
clinical and biopathological parameters in canine leishmaniasis. Eur J Epidemiol. 
2003;18:147-56.
 5. Ashford DA, Bozza M, Freire M, Miranda JC, Sherlock I, Eulalio C, et al. Comparison 
of the polymerase chain reaction and serology for the detection of canine visceral 
leishmaniasis. Am J Trop Med Hyg. 1995;53:251-5.
 6. Baneth G. Leishmaniasis. In: Greene CE, editor. Infectious diseases of the dog and cat. 
III. London: Saunders-Elsevier; 2006. p. 685-98.
 7. Barboza DCPM, Gomes Neto CMB, Lea DC, Bittencourt DVV, Carneiro AJB, Souza 
BMPS, et al. Estudo de coorte em áreas de risco para leishmaniose visceral canina, 
em municípios da região metropolitana de Salvador, Bahia, Brasil. Rev Bras Saúde 
Prod An. 2006;7:152-63.
 8. Berman JD. Human leishmaniasis: clinical, diagnostic and chemotherapeutic 
developments in the last 10 years. Clin Infect Dis. 1997;24:684-703.
 9. Churg J, Bernstein J, Glassock RJ. Renal disease: classification and atlas of glomerular 
diseases. New York: Igaku-Shoin; 1985.
 10. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular 
disease in the dog: a review of 137 cases (1985-1992). J Am Anim Hosp Assoc. 
1996;32:313-22.
 11. Costa FAL, Goto H, Saldanha LCB, Silva SMMS, Sinhorini IL, Silva TC, et al. 
Histopathologic patterns of nephropathy in naturally acquired canine visceral 
leishmaniasis. Vet Pathol. 2003;40:677-84.
 12. Costa FAL, Guerra JL, Silva SM, Klein RP, Mendonça IL, Goto H. CD4+ T cells 
participate in the nephropathy of canine visceral leishmaniasis. Braz J Med Biol Res. 
2000;33:1455-8.
 13. Costa FAL, Prianti MG, Silva TC, Silva SMMS, Guerra JL, Goto H. T cells, adhesion 
molecules and modulation of apoptosis in visceral leishmaniasis glomerulonephritis. 
BMC Infect Dis. 2010:10:112.
 14. Dias EL, Batista ZS, Guerra RMSNC, Calabrese KS, Lima TB, Abreu-Silva AL. Canine 
visceral leishmaniasis (CLV): seroprevalence, clinical, hematological and biochemical 
findings of dogs naturally infected in an endemic area of São José de Ribamar 
municipality, Maranhão State, Brazil. Ci Anim Bras. 2008;9:740-5.
 15. Dias MIR. Anestesia com indução pelo tiopental de sódio e manutenção pelo halotano 
no cão. Rev Port Ci Vet. 2000;95:71-80.
 16. Dos-Santos WLC, Jesus EE, Paranhos-Silva M, Pereira AM, Santos JC, Baleeiro CO, 
et al. Associations among immunological, parasitological and clinical parameters in 
canine visceral leishmaniasis: emaciation, spleen parasitism, specific antibodies and 
leishmanin skin test reaction. Vet Immunol Immunopathol. 2008;123:251-9.
 17. Dye C, Vidor E, Dereure J. Serological diagnosis of leishmaniasis: on detecting infection 
as well as disease. Epidemiol Infect. 1993;110:647-56.
 18. Gezoon. Gerência de Zoonozes de Teresina, Piauí. Teresina; 2010.
 19. Giunchetti RC, Mayrink W, Carneiro CM, Corrêa-Oliveira R, Martins-Filho OA, Marques 
MJ, et al. Histopathological and immunohistochemical investigations of the hepatic 
compartment associated with parasitism and serum biochemical changes in canine 
visceral leishmaniasis. Res Vet Sci. 2008;84:269-77.
 20. Gradoni L. The diagnosis of canine leishmaniasis. In: Canine leishmaniasis: moving 
towards a solution, 2002, Sevilla. Proceedings of the Second International Canine 
Leishmaniasis Forum. Sevilla; 2002. p. 7-15.
 21. Grauer GF. Glomerulonephritis. Semin Vet Med Surg (Small Anim.). 1992;7:187-97.
 22. Kaneko JJ, Harvey DW, Bruss WL. Clinical biochemistry of domestic animals V. San 
Diego: Academic Press; 1997. 
 23. Koutinas AF, Polizopoulou ZS, Saridomichelakis MN, Argyriadis D, Fytianou A, Plevraki 
KG. Clinical considerations on canine visceral leishmaniasis in Greece: a retrospective 
study of 158 cases (1989–1996). J Am Anim Hosp Assoc. 1999;35:376-83.
 24. Lainson R, Shaw JJ. A brief history of the genus Leishmania (Protozoa: Kinetoplastida) 
in the Americas with particular reference to Amazonian Brazil. Ci Cult. 1992;4:94-
106.
 25. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, 
Lillick-Kendrick R. The leishmaniasis in biology and medicine. London: Academic 
Press; 1987.
 26. Lopes STA, Biondo AW, Santos AP. Manual de patologia clínica veterinária. Santa Maria: 
UFSM - Universidade Federal de Santa Maria; 2007. 
 27. Luna GL. Manual of histologic staining methods of the Armed Forces Institute of 
Pathology. 3rd ed. New York: McGraw Hill; 1968. 
 28. Madeira MF, Figueiredo FB, Pinto AG, Nascimento LD, Furtado M, Mouta-Confort E, 
et al. Parasitological diagnosis of canine visceral leishmaniasis: is intact skin a good 
target? Res Vet Sci. 2009;87:260-2.
 29. Maia C, Nunes M, Cristóvão J, Campino L. Experimental canine leishmaniasis: clinical, 
parasitological and serological follow-up. Acta Trop. 2010;116:193-9.
 30. Matos MM, Filgueira KD, Amora SSA, Suassuna ACD, Ahid SMM, Alves ND. Ocorrência 
da leishmaniose visceral em cães em Mossoró, Rio Grande do Norte. Ci Anim. 
2006;16:51-4.
 31. Maurício IL, Stothard JR, Miles MA. The strange case of Leishmania chagasi. Parasitol 
Today. 2000;16:188-9.
 32. Melby Jr EC, Altman NH. Handbook of laboratory animal science III. Miami: CRC Press; 
1976.
 33. Michalsky EM, Rocha MF, Lima ACR, França-Silva JC, Pires MQ, Oliveira FS, et al. 
Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, 
to Lutzomyia longipalpis phlebotomine sand flies. Vet Parasitol. 2007;147:67-76.
 34. Ministério da Saúde. Brasil. Manual de vigilância e controle da leishmaniose visceral. 
Brasília; 2006. 
ALVES, G.B.B.; SILVA, L.S.; BATISTA, J.F.; CAMPOS, A.P.; PRIANTI, M.G. & COSTA, F.A.L. - The sero-conversion and evaluation of renal alterations in dogs infected by Leishmania 
(Infantum) chagasi. Rev. Inst. Med. Trop. Sao Paulo, 55(2): 105-12, 2013.
112
 35. Molina R, Amela C, Nieto J, San-Andrés M, González F, Castillo JA, et al. Infectivity 
of dogs naturally infected with Leishmania infantum to colonized Phlebotomus 
perniciosus. Trans R Soc Trop Med Hyg. 1994;88:491-3.
 36. Moshfea A, Mohebalia M, Edrissiana G, Zarei Z; Akhoundia B, Kazemid B, et al. 
Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum 
infection. Acta Trop. 2009;112:101-5.
 37. Oliveira LCP, Araújo RR, Alves, CR, Mouta-Confort E, López JA, Mendonça-Lima FW. 
Seroprevalence and risk factors for canine visceral leishmaniasis in the endemic area 
of Dias D’Ávila, State of Bahia, Brazil. Rev Soc Bras Med Trop. 2010;43:400-4.
 38. Otranto D, Paradies P, De Caprariis D, Stanneck D, Testini G, Grimm F, et al. Toward 
diagnosing Leishmania infantum infection in asymptomatic dogs in an area where 
leishmaniasis is endemic. Clin Vaccine Immunol. 2009;16:337-43.
 39. Paradies P, Sasanelli M, De Caprariis D, Testini G, Traversa D, Lia RP, et al. Clinical 
and laboratory monitoring of dogs naturally infected by Leishmania infantum. Vet 
J. 2010;186:370-3.
 40. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernardina W, Del Real G, Ruitenberg J. 
Cellular and humoral responses in dogs experimentally and naturally infected with 
Leishmania infantum. Infect Immun. 1994;62:229-35.
 41. Pozio E, Grandoni L, Bettini S, Gramiccia M. Leishmaniasis in Tuscany (Italy). VI. Canine 
leishmaniasis in the focus of Monte Argentario (Grosseto). Acta Trop. 1981;38:383-
93.
 42. Quinnell RJ, Courtenay O, Garcez LM, Kaye PM, Shaw MA, Dye C, et al. IgG subclass 
responses in a longitudinal study of canine visceral leishmaniasis. Vet Immunol 
Immunopathol. 2003;91:161-8.
 43. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Carvalho MG, Mayrink W, França-
Silva JC, et al. Parasite density and impaired biochemical/hematological status are 
associated with severe clinical aspects of canine visceral leishmaniasis. Res Vet Sci. 
2006;81:68-75.
 44. Reis AB, Martins-Filho OA, Teixeira-Carvalho A, Giunchetti RC, Carneiro CM, Mayrink 
W, et al. Systemic and compartmentalized immune response in canine visceral 
leishmaniasis. Vet Immunol Immunopathol. 2009;128:87-95.
 45. Secretaria do Planejamento do Piauí. Bairros. Teresina, PI, 2010. [Cited: 2010 Dec 20]. 
Available from: <http://www.teresina.pi.gov.br:8080/semplan/thebairros.asp> 
 46. Secretaria Estadual da Saúde do Piauí. Coordenação de Vigilância em Saúde Ambiental. 
Programa de Controle das Leishmanioses. Série histórica de 1998 a 2008. Teresina; 
2009.
 47. Shaw JJ. Further thoughts on the use of the name Leishmania (Leishmania) infantum 
chagasi for the aetiological agent of American visceral leishmaniasis. Mem Inst 
Oswaldo Cruz. 2006;101:577-9.
 48. Shaw JJ. New World leishmaniasis: the ecology of leishmaniasis and the diversity of 
leishmanial species in Central and South America. In: Farrell J. World Class Parasites: 
Leishmania. Boston: Kluwer Academic Publishers; 2002. p.11-31.
 49. Silva AV, Paula AA, Pereira DP, Brazil RP, Carreira JCA. Canine leishmaniasis in Brazil: 
serological follow-up of a dog population in an endemic area of American visceral 
leishmaniasis. J Parasitol Res. 2009;2009:680790.
 50. Soares MRA, Mendonça IL, Bonfim JM, Rodrigues JA, Werneck GL, Costa CHN. Canine 
visceral leishmaniasis in Teresina, Brazil: relationship between clinical features and 
infectivity for sand flies. Acta Trop. 2011;117:6-9.
 51. Tisher CC, Brenner BM. Renal pathology: with clinical and functional correlations. 2. 
ed. Philadelphia: J. B. Lippincott; 1994. 
 52. Zatelli A, Borgarelli M, Santilli R, Bonfanti U, Nigrisoli E, Zanatta R, et al. Glomerular 
lesions in dogs infected with Leishmania organisms. Am J Vet Res. 2003;64:558-61.
Received: 17 May 2012
Accepted: 21 August 2012
